Larry Robbins Pitches Thermo Fisher, Danaher – ValueWalk Premium
Larry Robbins

Larry Robbins Pitches Thermo Fisher, Danaher

Larry Robbins is the Founder, Portfolio Manager and CEO of Glenview Capital Management, a $7.5 billion hedge fund in its 14th year of operation and headquartered in New York City. Glenview is focused on delivering attractive absolute returns through an intense focus on deep fundamental research and individual security selection.? Larry Robbins spoke at the Capitalize For Kids Conference in Toronto and presented his favorite ideas. Below are some (very) informal notes from Robbins who explained why he likes Thermo Fisher Scientific Inc. (NYSE:TMO), Danaher Corporation (NYSE:DHR), Endo International plc (NASDAQ:ENDP) and Actavis plc (NYSE:ACT).

ValueWalk covered the conference today and tomorrow. Sign up for our free newsletter to ensure you do not miss any coverage.

Also see: Jeff Smith Bullish On Yahoo, Darden, MeadWestvacoJamie Dinan Likes TWC As Merger Arb Idea; TAP As Event Driven IdeaGuy Gottfried Pitches Long Tree Island Steel At Capitalize For Kids and Lee Ainslie Pitches Long Qihoo 360 At Capitalize For Kids, Vanshap Likes Keck Seng, Fleetwood; BHR Capital Long GLNG, Frank Brosens Of Taconic Sees Value In JOSB, MW Saga, Jacob Doft Of Highline Explains The Bullish Case For ICE, Jeff Hales Of Alignvest Capital Bullish On Corby Spirit And Wine, Sahm Adrangi Of Kerrisdale Is Bullish On SSNC And CTSH and Capitalize For Kids: Aaron Cowen Long BKW, LBTYA; Jody LaNasa Likes FIG, KODK

Larry Robins of Glenview Capital


Looks for:

-excess cash


-Unused Debt Capacity

-Incremental Debt Capacity

-Defensible Growth



Larry Robbins on Thermo Fisher Scientific Inc. (NYSE:TMO)

High fcf conversion

Can de-lever quickly


Larry Robbins on Danaher Corporation (NYSE:DHR)

Strong pricing power

Margin improvement opportunities

Large insider ownership

Now a life sciences company


Larry Robbins on Endo International plc (NASDAQ:ENDP)

Pharmaceutical company


Actavis plc (NYSE:ACT)

Larry Robbins Pitches Thermo Fisher, Danaher

Tom Saberhagen

Chuck Akre established Akre Capital Management in 1989 and continues to be the primary person responsible for the company's investment advisory services & investment selection. He has been in the securities business since 1968. He previously held positions as shareholder, Director, CEO of Asset Management Division and Director of Research at Johnston, Lemon & Co (a NYSE member firm). Chuck holds a BA in English Literature from American University. Tom Saberhagen of Akre Capital pitches Danaher Corporation (NYSE:DHR), Colfax Corp (NYSE:CFX) and Markel Corporation (NYSE:MKL).

Tom Saberhagen of Akre Capital

Run a hedge fund and a mutual fund


Look for business with high ROE, ROIC

“Compounding machines!” that also buy back shares



Danaher Corporation (NYSE:DHR) – high cash returns on tangible capital

Colfax Corp (NYSE:CFX)

Markel Corporation (NYSE:MKL)


Saved Articles